IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 143 filers reported holding IMMUNOGEN INC in Q1 2014. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,739,070 | -16.5% | 1,180,744 | -0.7% | 0.01% | -14.3% |
| Q2 2023 | $22,440,154 | +390.4% | 1,189,219 | -0.2% | 0.01% | +250.0% |
| Q1 2023 | $4,575,836 | +38271.8% | 1,191,797 | -50.4% | 0.00% | -50.0% |
| Q4 2022 | $11,925 | -99.9% | 2,404,056 | -5.4% | 0.00% | -20.0% |
| Q3 2022 | $12,145,000 | +67.5% | 2,540,851 | +57.7% | 0.01% | +66.7% |
| Q2 2022 | $7,249,000 | +4669.1% | 1,611,076 | +7752.4% | 0.00% | – |
| Q4 2021 | $152,000 | -78.3% | 20,517 | -83.4% | 0.00% | – |
| Q3 2021 | $699,000 | -80.0% | 123,226 | -76.7% | 0.00% | -100.0% |
| Q2 2021 | $3,492,000 | +49785.7% | 529,821 | +48065.5% | 0.00% | – |
| Q4 2014 | $7,000 | -41.7% | 1,100 | 0.0% | 0.00% | – |
| Q3 2014 | $12,000 | -7.7% | 1,100 | 0.0% | 0.00% | – |
| Q2 2014 | $13,000 | -18.8% | 1,100 | 0.0% | 0.00% | – |
| Q1 2014 | $16,000 | -11.1% | 1,100 | -12.0% | 0.00% | – |
| Q4 2013 | $18,000 | -14.3% | 1,250 | 0.0% | 0.00% | – |
| Q3 2013 | $21,000 | -19.2% | 1,250 | -19.4% | 0.00% | – |
| Q2 2013 | $26,000 | – | 1,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |